Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery - Trial NCT06286150
Access comprehensive clinical trial information for NCT06286150 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital of Guangzhou Medical University and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The First Affiliated Hospital of Guangzhou Medical University
Timeline & Enrollment
N/A
Sep 15, 2023
Jul 15, 2027
Primary Outcome
Intraoperative conversion rate,Surgical complications rate
Summary
Robotic surgical systems have become a promising surgical assistance system, with unique
 advantages such as 3D high-definition visual system, highly flexible wrist-jointed
 instruments, and automatic fitering of hand tremors. Robotic surgical systems is applied in
 various fields including urology, general surgery, cardiothoracic surgery, head and neck
 surgery, and gynecology. Currently, the Da Vinci surgical robot system is the most widely
 used robot system globally. However, the Da Vinci robot system for single-port laparoscopic
 surgery has not yet been launched in China. Therefore, the investigators conduct a
 prespective, single-center study to evaluate the efficacy and safety of single-port surgical
 robot system in thoracic surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06286150
Non-Device Trial